Over the forecast period from 2024 to 2028, the R&D budget for Health and Medical Sciences in France shows a consistent upward trend. The budget increases from $4.9 billion in 2024 to $5.37 billion by 2028, indicating a steady commitment to advancing health and medical research.
The year-on-year budget variation has demonstrated positive growth, with a notable rise of around 2.45% from 2024 to 2025, followed by a subsequent annual growth rate of approximately 2.19%, 2.34%, and 2.29% for the years 2026, 2027, and 2028, respectively.
To contextualize, in 2023, the actual R&D budget stood at $4.8 billion. Given this, the CAGR over the past five years (2023-2028) is approximately 2.28%.
Future trends to watch for include potential increases in investment linked to emerging medical technologies such as AI in healthcare, advancements in biotechnology, and ongoing public health challenges. Observing government policy changes and funding priorities will also be critical in predicting future allocations.
